Blood Type and Cancer Risk: What the Latest Research Reveals
For decades, scientists have investigated a potential link between a person’s ABO blood type and their risk of developing certain cancers. While not a definitive predictor, emerging research suggests a correlation between specific blood types and an increased or decreased susceptibility to various malignancies. This article explores the current understanding of these associations, backed by the latest scientific evidence.
The ABO Blood Group System and Cancer
The ABO blood group system is determined by the presence or absence of A and B antigens on the surface of red blood cells. Individuals are classified as having blood type A, B, AB, or O. Recent studies indicate that these blood types may influence cancer development through various mechanisms, including inflammation and immune response modulation.
Specific Blood Types and Cancer Risks
Blood Type A
Individuals with blood type A have been consistently linked to a higher risk of developing pancreatic cancer. This increased risk is potentially due to the role of ABO blood groups in regulating pro-inflammatory and adhesion molecules, factors known to contribute to chronic inflammation – a recognized driver of cancer development.
Blood Type B and AB
The relationship between blood types B and AB and cancer risk is more nuanced, varying depending on the cancer type. A 2017 study associated blood type AB with an increased risk of liver cancer. Further research is needed to fully understand these connections.
Blood Type O
Generally, individuals with blood type O appear to have a lower risk of developing pancreatic cancer compared to those with blood types A, B, or AB. The exact reasons for this protective effect are still under investigation.
Colorectal Cancer and Blood Type
Recent research has focused on the association between ABO blood groups and the progression of colorectal cancer. A retrospective cohort study published in January 2026 found that factors such as rectal tumor location, poorly differentiated tumors, tumor invasion depth (T3 and T4 stages), and extramural vein invasion were significantly associated with lymphatic spread in colorectal cancer patients. While the study didn’t specifically isolate blood type as a primary factor, it highlights the importance of understanding the interplay between various prognostic indicators.
Gastric Cancer and Blood Type
Studies have likewise investigated the correlation between ABO blood groups and metastatic gastric cancer, examining its relationship with histopathology, tumor localization, and overall survival. Further details on these findings are currently under investigation. More information is available on this topic.
Significant Considerations and Future Research
It’s crucial to emphasize that blood type is just one of many factors influencing cancer risk. Genetics, lifestyle, environmental exposures, and overall health play significant roles. Knowing your blood type doesn’t mean you will or won’t develop cancer; it simply indicates a potential predisposition.
Ongoing research continues to explore the complex relationship between ABO blood groups, and cancer. Future studies will likely focus on identifying the specific mechanisms by which blood types influence cancer development and progression, potentially leading to more personalized cancer prevention and treatment strategies.